According to Acumen Research and Consulting, the global Elastography Imaging market is expected to grow at noteworthy CAGR around 7.4 % throughout the forecast period and reach around US$ 3.2 billion by 2026.
Elastography is a method of medical imagery used to assess elastics and soft tissue stiffness. The most popular method of elastography for the map of stealth is the determination of various illnesses in the body: ultrasound and magnet resonance imaging. Biopsy is done as a totally non-invasive method in Elastography. Elastographic imagery is used to detect several cancers, like cancer of the breast, thyroid and prostate. The diagnosis of liver disease mainly involves elastography imaging. For musculoskeletal imaging, the specific form of elastoography is used to determine the mechanical characteristics and state of muscles and tendons. A method for magnetic resonance elastography, capable of measuring brain rigidity. Based on the source, elastographic imaging is categorized as static methods (strand imaging) or dynamic methods (shear wave imaging). Imaging Shear Wave involves methods like 1d elastography, sharp-shooting, shear-shooting, and MR elastography. Shear wave imagery involves
The report provides analysis of global Elastography Imaging market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.
One of the key market drivers is the increased incidence of chronic liver and breast cancer and the growing request for sophisticated diagnostic methods. The market is also anticipated to be fueling during the prediction era with high preferences for minimum or non-invasive operations. Patients and physicians, especially as a consequence of its non-invasive nature, and the exact evaluation of tissue mechanical characteristics, gain popularity and acceptance in elastography. Advanced systems of elastography offer both quantitative and qualitative details. The increased demand in emerging nations for sophisticated diagnostic methods is anticipated to replace traditional ultrasound with elastography, which will provide a significant boost to the industry. Wave shear elastography offers many benefits over other methods of diagnosis. The method helps to decrease biopsy requirements under different breast circumstances. It is commonly used to evaluate hepatic circumstances before and after the transplant and to track liver cirrhosis. The increasing occurrence of diseases in the breast and liver will increase the demand for elastographic devices.
Possible apps for early tumor detection are elastography. It can be used to identify small nodules in the glands correctly. The use of elastography in preventive healthcare is anticipated to boost. An increasing amount of continuing research are anticipated to boost the market during the prediction era to evaluate the prospective applications of elastography. Many of these research include ophthalmic applications, such as oculomotor-muscle analysis and corneal mechanical characteristics.
Due to advantages such as affordability, brief turnaround times and ready access, the ultrasound sector maintains the dominant share. Gradually, ultrasound elastography replaces standard equipment used for organ evaluation and biopsy. Due to its non-invasive nature, the magnetic resonance segment is anticipated to develop most rapidly between 2019 and 2026. This is the most popular method for the diagnosis of hepatic illnesses. An increasing use of magnetic resonance elastography is contributing to the development of this section owing to precise outcomes and painless process. The elastography of magnetic resonance is an efficient diagnostic instrument for advanced liver fibrosis. MRE thus helps measure the seriousness and the course of the therapy of liver diseases.
Due to growing use of elástography in ultrasound radiography and image-guided radiation treatment, the radiology segment is expected to lead the elastography imaging industry in the coming years. Applications for general imaging in radiology include cancer diagnosis and/or therapy, abdominal diseases and soft tissue wounds.
Easy worldwide availability of elastographic systems is anticipated to increase demand for these systems. In addition, the demand for radiology is anticipated to increase during the forecast period for various kinds of cancer, particularly breast cancer.
The incidence of cardiac disorders on a worldwide basis is anticipated to increase also significantly in the forecast period. In addition, the development of the segment will be expected to increase consumers ' disposable incomes and improve healthcare infrastructure in developing markets.
The segment of obstetrics is anticipated to show low development owing to stringent public requirements for the use of obstetric ultrasound machines. The market growth might be threatened. However, the market in urology and vascular profitable possibilities for development are anticipated to offer increased incidences of prostate cancer and increasing cases of vascular illnesses.
End Use Stance
Due to the growing amount of ultrasound and RMI-based elastography surgeries, this sector maintains a dominant market share. In addition, an growing number of cancer instances are anticipated to help the segment grow. The segment is anticipated to be driven during the forecast period by increasing acceptance by experts by noninvading surgical and diagnostic procedures at these centres. Moreover, increasing automation is expected to increase the demand for these devices in distinct hospital environments amongst surgeons and other experts. The segment is anticipated to be driven by an increased amount of imaging-led operations at ambulatory surgical centres. Increased numbers of instances of emergency fuel the adoption of elastographic imaging.
Due to the existence of a big amount of worldwide players in North America, the highest share will take place in the elastography imaging market during the forecast period. In addition, the national market is being driven by increased attempts by producers to market these technologies, and increasing significance for their use among end-users. In most developed countries of Europe, high healthcare spending drives the market. In addition, increasing public cancer screening projects, including the use of elastography ultrasound machines, contribute to market growth. The development in Asia Pacific over the forecast period is also anticipated to continue. The regional market is anticipated to be driven by increased geriatric populations, improvement of health facilities and fast economic growth. Economies like India, Japan and China, owing to rapid development of healthcare services, contribute significantly to growth in Asia-Pacific. Moreover, the regional market is contributing to increased government understanding of the therapeutic potential of ultrasound technology and the precise and rapid outcomes produced by the machines.
Global Elastography Imaging Market, By Modality
Global Elastography Imaging Market, By Application
Global Elastography Imaging Market, By End-use
Global Elastography Imaging Market, By Geography
The market research study on “Elastography Imaging Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Elastography Imaging market segments with market dynamics and their impact. The report also covers basic technology development policies.
This Report offers an assessment on the recent developments in the sector in each subsegment from 2010 to 2016. It predicts income development at the worldwide, regional, and nation levels. ARC has segmented the worldwide market report for elastography imagery on the modality, use, final use and region for the purpose of this research:
Key Players & Strategies
The leading players profiling on the market are Medison Co., Ltd.; Canon Medical Systems Corporation; Fujifilm Corporation ; Esaote SpA ; GE Healthcare; Koninklijke Philips N.V. ; Hitachi, Ltd. ; Mindray Bio-Medical Electronics Co., Ltd.
Key players focus on strategic alliances through partnerships or partnerships to create fresh concepts and grow their product portfolio. GE Healthcare has lately extended its partnership with SonoSim, for example. This cooperation aims to improve the ultrasound education of its customers.